Beta-Chemokine CCL15 Affects the Adhesion and Migration of Hematopoietic Progenitor Cells

Overview

Journal Transfus Med Hemother

Specialty Hematology

Date 2015 May 12

PMID 25960713

Citations 3

Authors

Rudolf Richter

Brigitte Ruster

Roxana Bistrian

Wolf-Georg Forssmann

Erhard Seifried

Reinhard Henschler

Affiliations

Soon will be listed here.

Abstract

Background: Hematopoietic stem and progenitor cell (HPC) motility is essential for HPC transplantation. The chemokine CXCL12 is key for HPC motility. Further regulators are of interest to improve HPC transplantation and regenerative medicine. Here the impact of the human chemokine CCL15 on HPC motility was investigated.

Methods: CCL15 plasma concentrations were determined during HPC mobilization in humans. Activity of CCL15 on HPCs was investigated in murine assays, including chemotaxis, adhesion, and CFU-A assays, and competitive repopulation assays.

Results: During HPC mobilization with granulocyte colony-stimulating factor, blood plasma contains increased concentrations (1.1 ± 0.1 ng/ml) of activated CCL15(27-92) versus 0.4 ± 0.1 ng/ml in controls (p = 0.02). CCL15(27-92) significantly enhanced CXCL12-induced transwell migration of Lin-/Sca1+ HPCs and strengthened shear stress-dependent adhesion to vascular cell adhesion molecule-1 (VCAM-1). CCL15(27-92) dose-dependently reduced the colony size in CFU-A assays performed with murine bone marrow and Lin-/Sca1+ HPCs. CCL15(27-92) did not show a direct impact on cell cycle status of HPCs. In murine repopulation assays, pretreatment of bone marrow with CCL15(27-92) significantly increased competitive repopulation.

Conclusion: Our results point to a regulation of HPCs by CCL15 by modulating migratory and adhesive properties of HPCs with the potency to improve HPC short-term engraftment in stem cell transplantation.

Citing Articles

Human Cytomegalovirus US28 Ligand Binding Activity Is Required for Latency in CD34 Hematopoietic Progenitor Cells and Humanized NSG Mice.

Crawford L, Caposio P, Kreklywich C, Pham A, Hancock M, Jones T mBio. 2019; 10(4).

PMID: 31431555 PMC: 6703429. DOI: 10.1128/mBio.01889-19.

The Biological and Clinical Relevance of G Protein-Coupled Receptors to the Outcomes of Hematopoietic Stem Cell Transplantation: A Systematized Review.

Golay H, Jurkovic Mlakar S, Mlakar V, Nava T, Ansari M Int J Mol Sci. 2019; 20(16).

PMID: 31404983 PMC: 6719093. DOI: 10.3390/ijms20163889.

Mechanisms of Sustained Neutrophilia in Patient WHIM-09, Cured of WHIM Syndrome by Chromothripsis.

Liu Q, Li Z, Yang A, Gao J, Velez D, J Cho E J Clin Immunol. 2017; 38(1):77-87.

PMID: 29177911 PMC: 5743603. DOI: 10.1007/s10875-017-0457-8.

References

Cashman J, Lapidot T, Wang J, Doedens M, Shultz L, Lansdorp P . Kinetic evidence of the regeneration of multilineage hematopoiesis from primitive cells in normal human bone marrow transplanted into immunodeficient mice. Blood. 1997; 89(12):4307-16. View

Laterveer L, Lindley I, Heemskerk D, Camps J, Pauwels E, Willemze R . Rapid mobilization of hematopoietic progenitor cells in rhesus monkeys by a single intravenous injection of interleukin-8. Blood. 1996; 87(2):781-8. View

Papayannopoulou T, Scadden D . Stem-cell ecology and stem cells in motion. Blood. 2008; 111(8):3923-30. PMC: 2288715. DOI: 10.1182/blood-2007-08-078147. View

Southam D, Widmer N, Ellis R, Hirota J, Inman M, Sehmi R . Increased eosinophil-lineage committed progenitors in the lung of allergen-challenged mice. J Allergy Clin Immunol. 2005; 115(1):95-102. DOI: 10.1016/j.jaci.2004.09.022. View

Kim W, Broxmeyer H, Han I, Park D, Lee K, Vinay D . Effect of leukotactin-1 on the protection in vivo of myeloid progenitor cells against cytotoxic chemotherapeutics. J Hematother Stem Cell Res. 2003; 12(1):107-13. DOI: 10.1089/152581603321210181. View

Bhatia M, Wang J, Kapp U, Bonnet D, Dick J . Purification of primitive human hematopoietic cells capable of repopulating immune-deficient mice. Proc Natl Acad Sci U S A. 1997; 94(10):5320-5. PMC: 24676. DOI: 10.1073/pnas.94.10.5320. View

Han I, Ra J, Kim M, Lee E, Jun H, Park S . Differentiation of CD34+ cells from human cord blood and murine bone marrow is suppressed by C6 beta-chemokines. Mol Cells. 2003; 15(2):176-80. View

Larochelle A, Vormoor J, Hanenberg H, Wang J, Bhatia M, Lapidot T . Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow: implications for gene therapy. Nat Med. 1996; 2(12):1329-37. DOI: 10.1038/nm1296-1329. View

Levesque J, Hendy J, Takamatsu Y, Williams B, Winkler I, Simmons P . Mobilization by either cyclophosphamide or granulocyte colony-stimulating factor transforms the bone marrow into a highly proteolytic environment. Exp Hematol. 2002; 30(5):440-9. DOI: 10.1016/s0301-472x(02)00788-9. View

10.

Youn B, Zhang S, Lee E, Park D, Broxmeyer H, Murphy P . Molecular cloning of leukotactin-1: a novel human beta-chemokine, a chemoattractant for neutrophils, monocytes, and lymphocytes, and a potent agonist at CC chemokine receptors 1 and 3. J Immunol. 1998; 159(11):5201-5. View

11.

Park S, Wolfram P, Canty K, Harley B, Nombela-Arrieta C, Pivarnik G . Focal adhesion kinase regulates the localization and retention of pro-B cells in bone marrow microenvironments. J Immunol. 2012; 190(3):1094-102. PMC: 3552136. DOI: 10.4049/jimmunol.1202639. View

12.

Caracciolo D, Shirsat N, Wong G, Lange B, Clark S, Rovera G . Recombinant human macrophage colony-stimulating factor (M-CSF) requires subliminal concentrations of granulocyte/macrophage (GM)-CSF for optimal stimulation of human macrophage colony formation in vitro. J Exp Med. 1987; 166(6):1851-60. PMC: 2188800. DOI: 10.1084/jem.166.6.1851. View

13.

Ottersbach K, Cook D, Kuziel W, Humbles A, Lu B, Gerard C . Macrophage inflammatory protein-1alpha uses a novel receptor for primitive hemopoietic cell inhibition. Blood. 2001; 98(12):3476-8. DOI: 10.1182/blood.v98.12.3476. View

14.

Pelus L, Fukuda S . Peripheral blood stem cell mobilization: the CXCR2 ligand GRObeta rapidly mobilizes hematopoietic stem cells with enhanced engraftment properties. Exp Hematol. 2006; 34(8):1010-20. DOI: 10.1016/j.exphem.2006.04.004. View

15.

Sahin A, Buitenhuis M . Molecular mechanisms underlying adhesion and migration of hematopoietic stem cells. Cell Adh Migr. 2012; 6(1):39-48. PMC: 3364136. DOI: 10.4161/cam.18975. View

16.

Stirling R, van Rensen E, Barnes P, Chung K . Interleukin-5 induces CD34(+) eosinophil progenitor mobilization and eosinophil CCR3 expression in asthma. Am J Respir Crit Care Med. 2001; 164(8 Pt 1):1403-9. DOI: 10.1164/ajrccm.164.8.2010002. View

17.

Escher S, Sticht H, Forssmann W, Rosch P, Adermann K . Synthesis and characterization of the human CC chemokine HCC-2. J Pept Res. 1999; 54(6):505-13. DOI: 10.1034/j.1399-3011.1999.00125.x. View

18.

Wang J, Lapidot T, Cashman J, Doedens M, Addy L, Sutherland D . High level engraftment of NOD/SCID mice by primitive normal and leukemic hematopoietic cells from patients with chronic myeloid leukemia in chronic phase. Blood. 1998; 91(7):2406-14. View

19.

Visser J, Bauman J, Mulder A, Eliason J, de Leeuw A . Isolation of murine pluripotent hemopoietic stem cells. J Exp Med. 1984; 159(6):1576-90. PMC: 2187316. DOI: 10.1084/jem.159.6.1576. View

20.

Graham G, Wright E, Hewick R, Wolpe S, Wilkie N, Donaldson D . Identification and characterization of an inhibitor of haemopoietic stem cell proliferation. Nature. 1990; 344(6265):442-4. DOI: 10.1038/344442a0. View